Awarded contract

Published

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

6 suppliers have saved this notice.

Looks like a fit? Save this tender and qualify it in Stotles

Value

321,349,256 GBP

Current supplier

Aventis Pharma Ltd

Description

NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/22/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. ## Contract award Title: NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins

Never miss a tender again

Get alerts, AI summaries and tools to qualify faster

Explore similar pre-tenders, open or awarded contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

NHS England

87,433,000 GBP

Published 14 hours ago

NHS England

150,085,000 GBP

Published 2 days ago

NHS England

25,881,000 GBP

Published 3 days ago

NHS Wales - Shared Services Partnership

14,410,853 GBP

Published 9 days ago

Northern Health and Social Care Trust

1,300,000 GBP

Published 10 days ago

University of East Anglia

0

Published 11 days ago

Ministry of Justice

3,000,000 GBP

Published 16 days ago

NHS England

39,406,040 GBP

Published 18 days ago

Western Health and Social Care Trust

4,638,166.35 GBP

Published 19 days ago

Explore top buyers for public sector contracts

Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.

Explore over 15,000 buyers

Sign up to the Stotles Tender Tracker for free

Find even more contracts with advanced search capability and AI powered relevance scoring.